During the past decade, North Alabama GI Research Center conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "North Alabama GI Research Center" #1 sponsor was "Hanmi Pharmaceutical Company Limited" with 1 trials, followed by "Intercept Pharmaceuticals" with 1 trials sponsored, "Inventiva Pharma" with 1 trials sponsored, "Sagimet Biosciences Inc." with 1 trials sponsored and "Tobira Therapeutics, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "North Alabama GI Research Center" are "Nonalcoholic Steatohepatitis" (2 trials), "Compensated Cirrhosis" (1 trials), "NASH - Nonalcoholic Steatohepatitis" (1 trials), "Non-Alcoholic Steatohepatitis (NASH)" (1 trials) and "Nonalcoholic Fatty Liver Disease" (1 trials). Many other conditions were trialed in "North Alabama GI Research Center" in a lesser frequency.

Most popular intervention types in "North Alabama GI Research Center" are "Drug" (5 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Cenicriviroc" (1 trials), "HM15211" (1 trials), "IVA337" (1 trials) and "Obeticholic acid (10 mg to 25 mg)" (1 trials). Other intervention names were less common.

The vast majority of trials in "North Alabama GI Research Center" are 5 trials for "All" genders.

Currently, there are NaN active trials in "North Alabama GI Research Center". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in North Alabama GI Research Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in North Alabama GI Research Center, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".